tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Advertisement

Janux Therapeutics Inc (JANX) Ownership - Who Owns Janux Therapeutics Inc?

Compare
421 Followers

Janux Therapeutics Inc (JANX) Ownership Overview

48.35%21.43%0.10%9.20%20.92%
48.35% Insiders
0.10% Other Institutional Investors
9.20% ETFs
20.92% Public Companies and
Individual Investors
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 30.73% of the company’s stock is owned by Institutional Investors, 48.35% is owned by Insiders, and 20.92% is owned by Public Companies and Individual Investors.
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 21.53% of the company’s stock is owned by Institutional Investors, 48.35% is owned by Insiders, and 9.20% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 07, 2025
xxxxxxxxxxxxx
$25342965
Oct 24, 2024
xxxxxxxxxxxxx
$178084
Oct 22, 2024
xxxxxxxxxxxxx
$53700000
Oct 18, 2024
xxxxxxxxxxxxx
$77472371

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$17064
Mar 31, 2025
xxxxxxxxxxxxx
$1352862
Mar 31, 2025
xxxxxxxxxxxxx
$26201124
Mar 31, 2025
xxxxxxxxxxxxx
$39341565

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,195,943Insider18.92%288,407,492
11,189,693Institution18.91%288,246,492
7,377,765Insider12.47%190,051,226
6,560,816Insider11.09%169,006,620
2,644,622Insider4.80%68,125,463
2,417,459Institution4.09%62,273,744
2,171,797Institution3.67%55,945,491
2,102,155Institution3.55%54,151,513
1,847,879Institution3.12%47,601,363
1,457,095Institution2.46%37,534,767

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,417,459Institution4.09%62,273,744
1,847,879Institution3.12%47,601,363
1,319,830Institution2.23%33,998,821
1,286,199Institution2.17%33,132,486
1,061,989Institution1.79%27,356,837
778,489Institution1.32%20,053,877
466,023Institution0.79%12,004,752
445,252Institution0.75%11,469,692
346,930Institution0.59%8,936,917
335,874Institution0.57%8,652,114

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,342,663Institution2.27%31,955,379
987,113Institution1.67%25,428,031
586,024Institution0.99%14,738,504
509,829Institution0.86%12,133,930
300,850Institution0.51%7,749,896
229,098Institution0.39%5,901,564
160,428Institution0.27%3,818,186
157,110Institution0.27%3,951,317
128,963Institution0.22%3,069,319
124,865Institution0.21%3,268,966

FAQ

Who Owns Janux Therapeutics Inc (JANX)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 48.35% is held by insiders, and 20.92% is held by retail investors.
    What percentage of Janux Therapeutics Inc (JANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.10% of Janux Therapeutics Inc (JANX) stock is held by institutional investors.
      What percentage of Janux Therapeutics Inc (JANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.92% of Janux Therapeutics Inc (JANX) stock is held by retail investors.
        Who owns the most shares of Janux Therapeutics Inc (JANX)?
        Ra Capital Management, Llc owns the most shares of Janux Therapeutics Inc (JANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis